Thursday 24 November 2011

One Touch Advanced Gel




Generic Name: benzocaine, butamben, tetracaine hydrochloride

Dosage Form: gel




Caution: Rx Only.

Do not use in eyes.  Keep out of reach of children.


Directions: Read package insert.

Press top of container to dispense desired amount.

Dispense 200 mg of gel (a bead approximately

1/4 to 1/2 inches long) by gently depressing the

pump.  Dispensing a bead in excess of 400 mg is

contraindicated.  Spread thinly and evenly over the

desired area using a cotton swab.


Active Ingredients: Benzocaine 14.0%,

Butamben 2.0%, Tetracaine Hydrochloride 2.0%

Inactive Ingredients: Benzalkonium Chloride

0.5%, Cetyl Dimethyl Ethyl Ammonium Bromide

0.005%, in a bland water-soluble base.
NDC 62565-901-01

OneTouch

Advanced



Topical Anesthetic Gel

OneTouch Advanced

is indicated for anesthesia of

accessible mucous membrane.



Cool Mint

Net Wt. 32 g



Store in a cool dry place.






Manufactured for:

HAGER

WORLDWIDE

Odessa, FL  33556 USA



Item #6256590101




Made in U.S.A.   Rev. 05/09

OneTouch

Advanced


Topical Anesthetic Gel                                                                                                                                                                           Rx Only









Active Ingredients:
Benzocaine
14.0%
Butamben
2.0%
Tetracaine Hydrochloride
2.0%
Inactive Ingredients:






Benzalkonium chloride
0.5%
Cetyl Dimethyl Ethyl Ammonium Bromide
0.005%
In bland, water-soluble base.

Action

The onset of OneTouch Advanced-produced anesthesia is rapid (approximately

30 seconds) and the duration of anesthesia is typically 30-60 minutes, when

used as directed. This effect is due to the rapid onset, but short duration of

action of Benzocaine coupled with the slow onset, but extended duration of

Tetracaine HCI and bridged by the intermediate action of Butamben.


It is believed that all of these agents act by reversibly blocking nerve conduc-­

tion. Speed and duration of action is determined by the ability of the agent to

be absorbed by the mucous membrane and nerve sheath and then to diffuse

out, and ultimately be metabolized (primarily by plasma cholinesterases) to inert

metabolites which are excreted in the urine.

Indications

OneTouch Advanced Gel is a topical anesthetic indicated for the production

of anesthesia of all accessible mucous membrane except the eyes. OneTouch

Advanced Gel is indicated for use to control pain in the mouth.



Dosage and Administration

Only a limited quantity is OneTouch Advanced Gel is required for anesthesia.


Dispense 200 mg of gel (a bead approximately 1/4 to 1/2 inches long) by gently

depressing the pump.  Dispensing a bead of gel in excess of 400 mg is contrain-­

dicated. Spread thinly and evenly over the desired area using a cotton swab.


An appropriate pediatric dosage has not been established for OneTouch Ad-­

vanced Gel.


Dosages should be reduced in the debilitated elderly, acutely ill, and very young

patients.


Tissue need not be dried prior to application of OneTouch Advanced Gel. One-

Touch Advanced Gel should be applied directly to the site where pain control is

required. Anesthesia is produced within one minute with an approximate duration

of thirty minutes. Each 200 mg dose of OneTouch Advanced Gel contains 28 mg

of benzocaine, 4 mg of butamben and 4 mg of tetracaine HCI.


Adverse Reactions

Hypersensitivity Reactions: Unpredictable adverse reactions (i.e. hypersensi-­

tivity, including anaphylaxis) are extremely rare.


Localized allergic reactions may occur after prolonged or repeated use of any

aminobenzoate anesthetic. The most common adverse reaction caused by

local anesthetics is contact dermatitis characterized by erythema and pruritus

that may progress to vesiculation and oozing. This occurs most commonly in

patients following prolonged self-medication, which is contraindicated. If rash,

urticaria, edema, or other manifestations of allergy develop during use, the drug

should be discontinued. To minimize the possibility of a serious allergic reaction,

OneTouch Advanced Gel should not be applied for prolonged periods except

under continual supervision. Dehydration of the epithelium or an escharotic ef-­

fect may also result from prolonged contact.

Precaution: On rare occasions, methemoglobinemia has been reported in

connection with the use of benzocaine-containing products. Care should be

used not to exceed the maximum recommended dosage (see Dosage and

Administration). If a patient becomes cyanotic, treat appropriately to counteract

(such as with methylene blue, if medically indicated).


Use in Pregnancy: Safe use of One Touch Advanced Gel has not been

established with respect to possible adverse effects upon fetal development.

Therefore, OneTouch Advanced Gel should not be used during early pregnancy,

unless in the judgement of a physician, the potential benefits outweigh the un-­

known hazards. Routine precaution for the use of any topical anesthetic should

be observed when OneTouch Advanced Gel is used.

Contraindications

OneTouch Advanced Gel is not suitable and should never be used for injection.

Do not use on the eyes. To avoid excessive systemic absorption, OneTouch

Advanced Gel should not be applied to large areas of denuded or inflamed

tissue. OneTouch Advanced Gel should not be administered to patients who are

hypersensitive to any of its ingredients or to patients known to have cholinest-­

erase deficiencies. Tolerance may vary with status of the patient.

 

OneTouch Advanced Gel should not be used under dentures or cotton rolls, as

retention of the active gel ingredients under a denture or cotton roll could pos-­

sibly cause an escharotic effect. Routine precaution for the use of any topical

anesthetic should be observed when using OneTouch Advanced Gel.



How-Supplied

OneTouch Advanced Gel, 32 g jar











Cool Mint
NDC 62565-901-01
Strawberry Ice
NDC 62565-902-01
Bubble Gum
NDC 62565-903-01
Cherry
NDC 62565-904-01

Manufactured for

HAGER

WORLDWIDE

13322 Byrd Drive

Odessa, FL 33556 USA


Made in U.S.A.        Rev. 6/09







ONE TOUCH ADVANCED TOPICAL ANESTHETIC GEL  COOL MINT
benzocaine, butamben, tetracaine hydrochloride  gel










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)62565-901
Route of AdministrationTOPICAL, DENTALDEA Schedule    














Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOCAINE (BENZOCAINE)BENZOCAINE28 mg  in .2 g
BUTAMBEN (BUTAMBEN)BUTAMBEN4 mg  in .2 g
TETRACAINE HYDROCHLORIDE (TETRACAINE)TETRACAINE HYDROCHLORIDE4 mg  in .2 g






Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE1 mg  in .2 g


















Product Characteristics
Colorgreen (GREEN)Score    
ShapeSize
FlavorMINT (COOL MINT)Imprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
162565-901-011 JAR In 1 BOXcontains a JAR
132 g In 1 JARThis package is contained within the BOX (62565-901-01)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/01/2009


Labeler - HAGER WORLDWIDE, INC. (009277971)

Registrant - HAGER WORLDWIDE, INC. (009277971)









Establishment
NameAddressID/FEIOperations
HAGER WORLDWIDE, INC.009277971manufacture
Revised: 11/2011HAGER WORLDWIDE, INC.




More One Touch Advanced Gel resources


  • One Touch Advanced Gel Use in Pregnancy & Breastfeeding
  • One Touch Advanced Gel Support Group
  • 0 Reviews · Be the first to review/rate this drug

Wednesday 23 November 2011

Benzyl Penicillin-Fresenius Vials




Benzyl Penicillin-Fresenius Vials may be available in the countries listed below.


Ingredient matches for Benzyl Penicillin-Fresenius Vials



Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Benzyl Penicillin-Fresenius Vials in the following countries:


  • South Africa

International Drug Name Search

Monday 21 November 2011

Clopidogrel CT




Clopidogrel CT may be available in the countries listed below.


Ingredient matches for Clopidogrel CT



Clopidogrel

Clopidogrel besilate (a derivative of Clopidogrel) is reported as an ingredient of Clopidogrel CT in the following countries:


  • Germany

International Drug Name Search

Saturday 19 November 2011

Medesedan




Medesedan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Medesedan



Detomidine

Detomidine hydrochloride (a derivative of Detomidine) is reported as an ingredient of Medesedan in the following countries:


  • France

  • Switzerland

International Drug Name Search

Friday 18 November 2011

Oxecta


Generic Name: oxycodone (Oral route)


ox-i-KOE-done hye-droe-KLOR-ide


Oral route(Tablet, Extended Release)

Oxycodone hydrochloride is an opioid agonist and a Schedule II controlled substance with an abuse potential similar to morphine. Patients should be assessed for their clinical risks for opioid abuse or addiction prior to being prescribed opioids. Oxycodone hydrochloride controlled-release tablets are indicated for continuous, around the clock analgesia for an extended period of time; not for use on an as needed basis. The 60 mg and 80 mg tablets, a single dose greater than 40 mg, or a total daily dose greater than 80 mg, are only for use in opioid-tolerant patients as they may cause fatal respiratory depression when administered to patients who are not tolerant to the respiratory depressant effects of opioids. Oxycodone hydrochloride controlled-release tablets must be swallowed whole to avoid a rapid release of the drug which can be potentially fatal. Concomitant use with CYP3A4 inhibitors may result in an increase in oxycodone plasma concentrations and may cause potentially fatal respiratory depression .



Commonly used brand name(s)

In the U.S.


  • Dazidox

  • Eth-Oxydose

  • Oxecta

  • Oxycontin

  • Oxycontin CR

  • Oxydose

  • Oxyfast

  • Oxy IR

  • Roxicodone

  • Roxicodone Intensol

In Canada


  • Oxy-IR

Available Dosage Forms:


  • Tablet, Extended Release

  • Tablet

  • Capsule

  • Solution

Therapeutic Class: Analgesic


Chemical Class: Oxycodone


Uses For Oxecta


Oxycodone is used to relieve moderate to severe pain. It belongs to the group of medicines called narcotic analgesics (pain medicines). Oxycodone acts on the central nervous system (CNS) to relieve pain.


When oxycodone is used for a long time, it may become habit-forming, causing mental or physical dependence. However, people who have continuing pain should not let the fear of dependence keep them from using narcotics to relieve their pain. Mental dependence (addiction) is not likely to occur when narcotics are used for this purpose. Physical dependence may lead to withdrawal side effects if treatment is stopped suddenly. However, severe withdrawal side effects can usually be prevented by gradually reducing the dose over a period of time before treatment is stopped completely.


This medicine is available only with your doctor's prescription.


Before Using Oxecta


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of oxycodone in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of oxycodone in the elderly. However, elderly patients are more likely to have age-related liver or kidney problems, which may require caution and an adjustment in the dose for patients receiving oxycodone.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Naltrexone

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acetophenazine

  • Adinazolam

  • Alfentanil

  • Alprazolam

  • Amobarbital

  • Anileridine

  • Aprobarbital

  • Atazanavir

  • Brofaromine

  • Bromazepam

  • Brotizolam

  • Buprenorphine

  • Buspirone

  • Butabarbital

  • Butalbital

  • Butorphanol

  • Carisoprodol

  • Chloral Hydrate

  • Chlordiazepoxide

  • Chlorpromazine

  • Chlorzoxazone

  • Clarithromycin

  • Clobazam

  • Clonazepam

  • Clorazepate

  • Clorgyline

  • Codeine

  • Dantrolene

  • Desflurane

  • Dexmedetomidine

  • Dezocine

  • Diazepam

  • Diphenhydramine

  • Doxylamine

  • Enflurane

  • Erythromycin

  • Escitalopram

  • Estazolam

  • Eszopiclone

  • Ethchlorvynol

  • Ethopropazine

  • Fentanyl

  • Flumazenil

  • Flunitrazepam

  • Fluphenazine

  • Flurazepam

  • Fluvoxamine

  • Fospropofol

  • Furazolidone

  • Halazepam

  • Halothane

  • Hydrocodone

  • Hydromorphone

  • Hydroxyzine

  • Indinavir

  • Iproniazid

  • Isocarboxazid

  • Isoflurane

  • Itraconazole

  • Ketamine

  • Ketazolam

  • Ketoconazole

  • Lazabemide

  • Levorphanol

  • Linezolid

  • Lorazepam

  • Lormetazepam

  • Medazepam

  • Meperidine

  • Mephenesin

  • Mephobarbital

  • Meprobamate

  • Mesoridazine

  • Metaxalone

  • Methdilazine

  • Methocarbamol

  • Methohexital

  • Midazolam

  • Moclobemide

  • Morphine

  • Morphine Sulfate Liposome

  • Nalbuphine

  • Nefazodone

  • Nelfinavir

  • Nialamide

  • Nitrazepam

  • Nitrous Oxide

  • Nordazepam

  • Opium

  • Oxazepam

  • Oxycodone

  • Oxymorphone

  • Pargyline

  • Pentazocine

  • Pentobarbital

  • Perphenazine

  • Phenelzine

  • Phenobarbital

  • Prazepam

  • Procarbazine

  • Prochlorperazine

  • Promazine

  • Promethazine

  • Propiomazine

  • Propofol

  • Propoxyphene

  • Quazepam

  • Ramelteon

  • Rasagiline

  • Remifentanil

  • Ritonavir

  • Saquinavir

  • Secobarbital

  • Selegiline

  • Sertraline

  • Sevoflurane

  • Sodium Oxybate

  • Sufentanil

  • Tapentadol

  • Telithromycin

  • Temazepam

  • Thiethylperazine

  • Thiopental

  • Thioridazine

  • Toloxatone

  • Tranylcypromine

  • Triazolam

  • Trifluoperazine

  • Triflupromazine

  • Trimeprazine

  • Zaleplon

  • Zolpidem

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Miconazole

  • Rifampin

  • St John's Wort

  • Voriconazole

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following is usually not recommended, but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.


  • Ethanol

Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Addison's disease (adrenal gland problem) or

  • Alcohol abuse, or history of or

  • Brain tumor, history of or

  • Breathing problems (e.g., hypoxia) or

  • Cancer of the esophagus or colon or

  • Central nervous system (CNS) depression or

  • Chronic obstructive pulmonary disease (COPD) or

  • Cor pulmonale (serious heart condition) or

  • Drug dependence, especially with narcotics, or history of or

  • Enlarged prostate (BPH, prostatic hypertrophy) or

  • Gallbladder disease or gallstones or

  • Head injuries, history of or

  • Hypothyroidism (an underactive thyroid) or

  • Hypovolemia (low blood volume) or

  • Kyphoscoliosis (curvature of the spine with breathing problems) or

  • Problems with passing urine or

  • Psychosis (a mental disease) or

  • Trouble with swallowing or

  • Weakened physical condition—Use with caution. May increase risk for more serious side effects.

  • Asthma, severe or

  • Hypercarbia (high carbon dioxide in the blood) or

  • Paralytic ileus (intestine stops working and may be blocked) or

  • Respiratory depression (very slow breathing)—Should not be used in patients with these conditions.

  • Hypotension (low blood pressure) or

  • Pancreatitis (inflammation of the pancreas) or

  • Seizures, history of—Use with caution. May make these conditions worse.

  • Kidney disease, severe or

  • Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of oxycodone

This section provides information on the proper use of a number of products that contain oxycodone. It may not be specific to Oxecta. Please read with care.


Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. This is especially important for elderly patients, who may be more sensitive to the effects of pain medicines. If too much of this medicine is taken for a long time, it may become habit-forming (causing mental or physical dependence).


This medicine comes with a patient information leaflet. Read and follow these instructions carefully. Ask your doctor if you have any questions.


Oxycodone extended-release tablets should only be used by patients who have already been taking narcotic pain medicines, also called opioids. These patients are called opioid-tolerant. If you are uncertain whether or not you are opioid-tolerant, check with your doctor before using this medicine.


Measure the oral liquid concentrate with the calibrated dropper that comes with the package. Your doctor may have you mix the concentrate with a small amount of liquid or food. Carefully follow the instructions and take the medicine mixture right away.


Measure the oral liquid with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid.


Swallow the Oxecta® or OxyContin® tablet whole with water. Do not break, crush, cut, chew, or dissolve it. Do not pre-soak, lick, or wet the tablet before placing it in the mouth. Take one tablet at a time. Also, do not give this medicine through nasogastric or feeding tubes.


Oxycodone extended-release tablets work differently from the regular oxycodone oral solution or tablets, even at the same dose. Do not switch from one brand or form to the other unless your doctor tells you to.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (extended-release tablets):
    • For moderate to severe pain:
      • Patients switching from regular oxycodone forms:
        • Adults—The tablet is given every 12 hours. The total amount of milligrams (mg) per day is the same as the total amount of regular oxycodone that is taken per day. The total amount per day will be divided and given as 2 doses during the day. Your doctor may adjust your dose if needed.

        • Children—Use and dose must be determined by your doctor.


      • Patients switching from other narcotic medicines:
        • Adults—The tablet is given every 12 hours. The total amount of milligrams (mg) per day will be determined by your doctor and depends on which narcotic you were using. The total amount per day will be divided and given as 2 doses during the day. Your doctor may adjust your dose if needed.

        • Children—Use and dose must be determined by your doctor.


      • Patients who are not taking narcotic medicines:
        • Adults—At first, 10 milligrams (mg) every 12 hours. Your doctor may adjust your dose if needed.

        • Children—Use and dose must be determined by your doctor.




  • For oral dosage form (immediate-release tablets):
    • For moderate to severe pain:
      • Patients who are not taking narcotic medicines:
        • Adults—At first, 5 to 15 milligrams (mg) every 4 to 6 hours as needed. Your doctor may adjust your dose if needed.

        • Children—Use and dose must be determined by your doctor.


      • Patients switching from fixed-ratio oral narcotic/non-narcotic combinations:
        • Adults—Your doctor will determine whether or not to continue the non-narcotic pain medicine. Also, the total amount of milligrams (mg) per day will be determined by your doctor and depends on which narcotic you were using. Your doctor may adjust your dose if needed.

        • Children—Use and dose must be determined by your doctor.


      • Patients switching from other narcotic medicines:
        • Adults—The total amount of milligrams (mg) per day will be determined by your doctor and depends on which narcotic you were using. Your doctor may adjust your dose if needed.

        • Children—Use and dose must be determined by your doctor.




  • For oral dosage forms (liquid concentrate, solution, or tablets):
    • For moderate to severe pain:
      • Adults—10 to 30 milligrams (mg) every 4 hours as needed. Your doctor may adjust your dose if needed.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Oxycodone can cause serious unwanted effects if taken by adults who are not used to strong narcotic pain medicines, children, or pets. Make sure you store the medicine in a safe and secure place to prevent others from getting it.


Flush the unused extended-release tablets and immediate-release tablets down the toilet.


Precautions While Using Oxecta


It is very important that your doctor check your progress while you are taking this medicine. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it.


This medicine will add to the effects of alcohol and other CNS depressants (medicines that can make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for allergies or colds; sedatives, tranquilizers, or sleeping medicine; other prescription pain medicine or narcotics; medicine for seizures or barbiturates; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of these medicines while you are using this medicine.


This medicine may be habit-forming. If you feel that the medicine is not working as well, do not use more than your prescribed dose. Call your doctor for instructions.


Dizziness, lightheadedness, or fainting may occur when you get up suddenly from a lying or sitting position. Getting up slowly may help lessen this problem. Also, lying down for a while may relieve the dizziness or lightheadedness.


This medicine may make you dizzy, drowsy, or lightheaded. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert.


Using narcotics for a long time can cause severe constipation. To prevent this, your doctor may direct you to take laxatives, drink a lot of fluids, or increase the amount of fiber in your diet. Be sure to follow the directions carefully, because continuing constipation can lead to more serious problems.


If you have been using this medicine regularly for several weeks or longer, do not change your dose or suddenly stop using it without checking with your doctor. Your doctor may want you to gradually reduce the amount you are using before stopping it completely. This may help prevent worsening of your condition and reduce the possibility of withdrawal symptoms, such as abdominal or stomach cramps, anxiety, fever, nausea, runny nose, sweating, tremors, or trouble with sleeping.


Using this medicine while you are pregnant may cause serious unwanted effects in your newborn baby. Tell your doctor right away if you think you are pregnant or if you plan to become pregnant while using this medicine.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


Oxecta Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Less common
  • Chills

  • cold sweats

  • confusion

  • difficult or labored breathing

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • fever

  • shortness of breath

  • tightness in the chest

  • twitching

  • wheezing

Rare
  • Abdominal or stomach pain

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • blood in the urine

  • burning while urinating burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

  • chest pain

  • convulsions

  • cough

  • decrease in the frequency of urination

  • decrease in urine volume

  • decreased urine output

  • difficult or painful urination

  • difficulty in passing urine (dribbling)

  • difficulty with swallowing

  • dizziness

  • dry mouth

  • fainting

  • fast or irregular heartbeat

  • fast, irregular, pounding, or racing heartbeat or pulse

  • feeling of warmth or heat

  • flushing or redness of the skin, especially on the face and neck

  • frequent urination

  • headache

  • hives

  • increase in heart rate

  • increased thirst

  • increased volume of pale, dilute urine

  • itching

  • lightheadedness

  • muscle pain or cramps

  • nausea or vomiting

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • rapid breathing

  • rapid weight gain

  • severe constipation

  • severe vomiting

  • shakiness in the legs, arms, hands, or feet

  • skin rash

  • sunken eyes

  • sweating

  • swelling or puffiness of the face

  • swollen, painful, or tender lymph glands in the neck, armpit, or groin

  • thirst

  • tingling of the hands or feet

  • trembling or shaking of the hands or feet

  • unusual tiredness or weakness

  • unusual weight gain or loss

  • wrinkled skin

Incidence not known
  • Blurred vision

  • choking

  • clay-colored stools

  • cold, clammy skin

  • dark urine

  • diarrhea

  • fast, weak pulse

  • gagging

  • irregular, fast, slow, or shallow breathing

  • loss of appetite

  • low blood pressure or pulse

  • pale or blue lips, fingernails, or skin

  • trouble with swallowing

  • unconsciousness

  • unpleasant breath odor

  • very slow breathing

  • very slow heartbeat

  • yellow eyes or skin

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Change in consciousness

  • chest pain or discomfort

  • constricted, pinpoint, or small pupils (black part of the eye)

  • decreased awareness or responsiveness

  • extreme drowsiness

  • loss of consciousness

  • no muscle tone or movement

  • severe sleepiness

  • slow or irregular heartbeat

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Difficulty having a bowel movement (stool)

  • drowsiness

  • lack or loss of strength

  • relaxed and calm feeling

  • sleepiness or unusual drowsiness

Less common
  • Abnormal dreams

  • acid or sour stomach

  • anxiety

  • belching

  • burning feeling in the chest or stomach

  • false or unusual sense of well-being

  • heartburn

  • hiccups

  • indigestion

  • nervousness

  • sleeplessness

  • stomach discomfort, upset, or pain

  • tenderness in the stomach area

  • trouble with sleeping

  • unable to sleep

  • weight loss

Rare
  • Absent, missed, or irregular menstrual periods

  • bad, unusual or unpleasant (after) taste

  • bloated or full feeling

  • body aches or pain

  • change in taste

  • change in walking and balance

  • changes in vision

  • clumsiness or unsteadiness

  • congestion

  • continuing ringing or buzzing or other unexplained noise in the ears

  • cracks in the skin

  • crying

  • decreased interest in sexual intercourse

  • dental caries or tooth decay

  • depersonalization

  • depression

  • difficulty with speaking

  • dry skin

  • dryness or soreness of the throat

  • dysphoria

  • excess air or gas in the stomach or intestines

  • excessive muscle tone

  • feeling of constant movement of self or surroundings

  • feeling of unreality

  • general feeling of discomfort or illness

  • headache, severe and throbbing

  • hearing loss

  • hives or welts

  • hoarseness

  • hyperventilation

  • inability to have or keep an erection

  • increase in body movements

  • increased appetite

  • increased cough

  • irritability

  • loss in sexual ability, desire, drive, or performance

  • loss of heat from the body

  • loss of memory

  • loss of strength or energy

  • mental depression

  • muscle pain or weakness

  • muscle stiffness

  • muscle tension or tightness

  • neck pain

  • paranoia

  • passing of gas

  • problems with memory

  • quick to react or overreact emotionally

  • rapidly changing moods

  • red, swollen skin

  • restlessness

  • runny nose

  • scaly skin

  • sensation of spinning

  • sense of detachment from self or body

  • severe sleepiness

  • stomach pain, fullness, or discomfort

  • stopping of menstrual bleeding

  • swelling or inflammation of the mouth

  • tender, swollen glands in the neck

  • unusual weak feeling

  • voice changes

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Oxecta side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Oxecta resources


  • Oxecta Side Effects (in more detail)
  • Oxecta Use in Pregnancy & Breastfeeding
  • Oxecta Drug Interactions
  • Oxecta Support Group
  • 0 Reviews for Oxecta - Add your own review/rating


Compare Oxecta with other medications


  • Pain

Articlox




Articlox may be available in the countries listed below.


Ingredient matches for Articlox



Hydroxocobalamin

Hydroxocobalamin acetate (a derivative of Hydroxocobalamin) is reported as an ingredient of Articlox in the following countries:


  • Greece

International Drug Name Search

Wednesday 16 November 2011

Zinkotase




Zinkotase may be available in the countries listed below.


Ingredient matches for Zinkotase



Zinc Aspartate

Zinc Aspartate is reported as an ingredient of Zinkotase in the following countries:


  • Germany

International Drug Name Search

Friday 11 November 2011

Lifo-Scrub




Lifo-Scrub may be available in the countries listed below.


Ingredient matches for Lifo-Scrub



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Lifo-Scrub in the following countries:


  • Greece

  • Switzerland

International Drug Name Search

Monday 7 November 2011

Elrox




Elrox may be available in the countries listed below.


Ingredient matches for Elrox



Roxithromycin

Roxithromycin is reported as an ingredient of Elrox in the following countries:


  • Russian Federation

International Drug Name Search

Nifeslow




Nifeslow may be available in the countries listed below.


Ingredient matches for Nifeslow



Nifedipine

Nifedipine is reported as an ingredient of Nifeslow in the following countries:


  • Japan

  • Luxembourg

International Drug Name Search

Saturday 5 November 2011

DBL Cefoxitin Sodium for Injection




DBL Cefoxitin Sodium for Injection may be available in the countries listed below.


Ingredient matches for DBL Cefoxitin Sodium for Injection



Cefoxitin

Cefoxitin sodium salt (a derivative of Cefoxitin) is reported as an ingredient of DBL Cefoxitin Sodium for Injection in the following countries:


  • Australia

  • New Zealand

International Drug Name Search